Стамарил

Стамарил is a live, attenuated yellow fever vaccine derived from the 17D-204 strain. It is used to provide immunity against yellow fever virus before travel to endemic regions. This vaccine is administered via intramuscular or subcutaneous injection.

Стамарил is indicated for active immunization against yellow fever in individuals aged 9 months and older. It is commonly recommended for travelers visiting areas where yellow fever is endemic or for those requiring proof of vaccination for entry. The vaccine stimulates the immune system to produce antibodies against the virus, offering long-term protection.

After administration, the vaccine prompts the body to develop an immune response to the yellow fever virus. Most individuals experience mild effects such as soreness at the injection site or low-grade fever. These reactions are typically temporary and indicate the vaccine is working as intended.

This vaccine should be stored and handled according to manufacturer guidelines to maintain its efficacy. It is important to inform healthcare providers of any allergies, especially to eggs or previous vaccine components. Individuals with weakened immune systems or certain medical conditions should consult a healthcare professional before receiving the vaccine.

Concurrent use with other live vaccines may require spacing between administrations. Immunosuppressive therapies, including corticosteroids, may reduce the vaccine's effectiveness. Patients undergoing such treatments should discuss timing with their healthcare provider. No specific food or drink restrictions are required.